Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility

被引：12

作者：

Carmen Puertas, Maria ^{[1
]}

Jose Buzon, Maria ^{[1
]}

Artese, Anna ^{[2
]}

Alcaro, Stefano ^{[2
]}

Menendez-Arias, Luis ^{[3
,4
]}

Perno, Carlo Federico ^{[5
]}

Clotet, Bonaventura ^{[1
]}

Ceccherini-Silberstein, Francesca ^{[5
]}

Martinez-Picado, Javier ^{[1
,6
]}

机构：

[1] IrsiCaixa Fdn, Hosp Germans Trias & Pujol, Badalona 08916, Spain

[2] Univ Catanzaro Magna Graecia, Dept Pharmacobiol Sci, Catanzaro, Italy

[3] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain

[4] Univ Autonoma Madrid, Madrid, Spain

[5] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy

[6] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain

来源：

JOURNAL OF VIROLOGY | 2009年 / 83卷 / 15期

关键词：

RESISTANCE MUTATIONS; ANTIRETROVIRAL THERAPY; ZIDOVUDINE RESISTANCE; VIROLOGICAL RESPONSE; EXPERIENCED PATIENTS; COMBINATION THERAPY; IN-VITRO; HIV-1; PATTERNS; INHIBITORS;

D O I：

10.1128/JVI.00487-09

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A negative association between polymorphism Leu-214 and type-1 thymidine analogue mutations (TAM1) and a positive association with a clinically favorable virological response to thymidine analogue-based combination antiretroviral therapy have been described. In this study, the impact of Leu-214 on replication capacity and resistance to zidovudine (ZDV) of viruses containing TAM1 or TAM2 was determined. Leu-214 decreased the growth rate of viruses bearing Tyr-215, as well as their resistance to ZDV. This observation was confirmed by structural and molecular modeling data, suggesting a regulatory role for Leu-214 in the emergence and phenotypic resistance of TAM1.

引用

页码：7434 / 7439

页数：6

共 36 条

[21] Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure [J].

Marcelin, AG ;

Delaugerre, C ;

Wirden, M ;

Viegas, P ;

Simon, A ;

Katlama, C ;

Calvez, V .

JOURNAL OF MEDICAL VIROLOGY, 2004, 72 (01) :162-165

[22] Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1 [J].

Martinez-Picado, J ;

Wrin, T ;

Frost, SDW ;

Clotet, B ;

Ruiz, L ;

Brown, AJL ;

Petropouios, CJ ;

Parkin, NT .

JOURNAL OF VIROLOGY, 2005, 79 (10) :5907-5913

[23] HIV-1 reverse transcriptase inhibitor resistance mutations and fitness:: A view from the clinic and ex vivo [J].

Martinez-Picado, Javier ;

Martinez, Miguel Angel .

VIRUS RESEARCH, 2008, 134 (1-2) :104-123

[24] Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism [J].

Meyer, PR ;

Matsuura, SE ;

So, RG ;

Scott, WA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13471-13476

[25] Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients [J].

Miller, MD ;

Margot, N ;

Lu, B ;

Zhong, LJ ;

Chen, SS ;

Cheng, A ;

Wulfsohn, M .

JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) :837-846

[26] MACROMODEL - AN INTEGRATED SOFTWARE SYSTEM FOR MODELING ORGANIC AND BIOORGANIC MOLECULES USING MOLECULAR MECHANICS [J].

MOHAMADI, F ;

RICHARDS, NGJ ;

GUIDA, WC ;

LISKAMP, R ;

LIPTON, M ;

CAUFIELD, C ;

CHANG, G ;

HENDRICKSON, T ;

STILL, WC .

JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (04) :440-467

[27] Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine [J].

Ntemgwa, Michel ;

Wainberg, Mark A. ;

Oliveira, Maureen ;

Moisi, Daniela ;

Lalonde, Richard ;

Micheli, Valeria ;

Brenner, Blurna G. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) :3861-3869

[28] Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing [J].

Rhee, SY ;

Liu, T ;

Ravela, J ;

Gonzales, MJ ;

Shafer, RW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) :3122-3126

[29] Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA [J].

Sarafianos, SG ;

Clark, AD ;

Das, K ;

Tuske, S ;

Birktoft, JJ ;

Ilankumaran, P ;

Ramesha, AR ;

Sayer, JM ;

Jerina, DM ;

Boyer, PL ;

Hughes, SH ;

Arnold, E .

EMBO JOURNAL, 2002, 21 (23) :6614-6624

[30] Correlation of phenotypic zidovudine resistance with mutational patterns in the reverse transcriptase of human immunodeficiency virus type 1:: Interpretation of established mutations and characterization of new polymorphisms at codons 208, 211, and 214 [J].

Stürmer, M ;

Staszewski, S ;

Doerr, HW ;

Larder, B ;

Bloor, S ;

Hertogs, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :54-61

← 1 2 3 4 →